Baclofen extended release - Intec Pharma

Drug Profile

Baclofen extended release - Intec Pharma

Alternative Names: Accordian pill baclofen; AP-Baclofen; Baclofen GR

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Intec Pharma
  • Class Aminobutyric acids; Antispastics; Muscle relaxants; Small molecules
  • Mechanism of Action GABA B receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Muscle spasticity

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for phase-I development in Muscle-spasticity in Israel (PO, Controlled release)
  • 22 Oct 2015 Intec Pharma has patent protection for Accordion Pill platform in Europe
  • 03 Aug 2009 Phase-I clinical trials in Spasticity in Israel (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top